*Breaking News* (OTC:BSEM) Increases Revs Over 1,000%!!

Huge News Out For: (OTC:BSEM)     Amniowrap2™ Product Launch Leads Year of Highlights for BioStem Technologies   Biostem Technologies   Tue, January 30, 2024, 2:05 PM MST             Biostem Technologies BioStem provides a business update and highlights recent accomplishments Preliminary fourth quarter net revenues of $11.5 million and full year 2023 net revenues of $16.7 million National Pricing for Amniowrap2™ effective January 1st in all 50 states and territories POMPANO BEACH, Fla., Jan. 30, 2024 (GLOBE NEWSWIRE) -- BioStem Technologies Inc . (OTC: BSEM), a leading regenerative medicine company focused on the development, manufacture, and commercialization of placental-derived allografts for advanced wound care, today highlights its 2023 accomplishments and provides a business update.   BioStem Technologies CEO, Jason Matuszewski, said, "2023 was a year of tremendous growth, progress and achievement for BioStem. This growth is primarily attributed to the successful launch of Amniowrap2™, our innovative placental-derived allograft product designed to address a broad spectrum of wound applications. A significant factor contributing to this success has been the widespread acceptance and utilization of Amniowrap2™ by medical professionals, underscoring its effectiveness and growing prominence in the healthcare industry.   "We remain committed to our mission of delivering unparalleled wound care solutions for patients and healthcare professionals, and look forward to broadening our reach into new markets in the next year. I want to thank the BioStem team for their unwavering dedication. I am very excited to see what we can achieve together in 2024 and beyond."   Financial updates for the year and quarter ended December 31, 2023: Preliminary net revenue for the fourth quarter 2023 was $11.5 million, (UNAUDITED) an increase of 1,351% from the same period in 2022. Total preliminary net revenue reached $16.7 million (UNAUDITED), in the fiscal year concluding on December 31, 2023, representing a 142% increase compared to the previous year.   Operational updates for the year and quarter ended December 31, 2023: In September 2023, BioStem entered into an agreement with Venture Medical, LLC., for the nationwide release of its innovative product, AmnioWrap2™. In addition, BioStem entered into a commercialization agreement with NovaBay Pharmaceuticals for its Amniotic Tissue Allograft, which will be used as a protective covering during the repair of ocular surfaces. In September 2023, the Company was successfully listed on key government contract vehicles, on the Department of Defense's Distribution and Pricing Agreement (DAPA), the Department of Veterans Affairs Federal Supply Schedule (FSS), and the Defense Logistics Agency's ECAT system. This listing was made possible by BioStem's Service-Disabled Veteran-Owned Small Business (SDVOSB) exclusive partner, Lovell Government Services. Recent achievements: January 2024 BioStem Technologies appointed a proven life science sales leader, Mr. Shawn McCarrey, as Chief Commercial Officer. Effective January 1, 2024, the Center for Medicare Services Established National Pricing for AmnioWrap2TM in all 50 states and territories. BioStem's Healthcare Common Procedure Coding System (HCPCS) code for VENDAJE AC® became effective. December 2023 BioStem added industry leaders, Mr. Thomas J. Dugan and Mr. Patrick Daly, to its Board of Directors. November 2023 BioStem was awarded a Q code for VENDAJE AC® by the Centers for Medicare and Medicaid Services (CMS). The Company closed an oversubscribed private placement for gross proceeds of $2 million. October 2023 BioStem announced the opening of the first clinical site for a study that will evaluate its Vendaje® tissue allograft in the treatment of diabetic foot ulcers (DFU). Fourth quarter and full year 2023 financial results conference call BioStem will host a conference call and webcast to discuss fourth quarter and full year 2023 financial results in March 2024. BioStem has used, and intends to continue to use, its investor relations website, as a means of disclosing material, non-public information, and for complying with its disclosure obligations under Regulation FD. The unaudited results in this press release are preliminary and subject to the completion of the Company's annual independent audit and, therefore, are subject to adjustment.     Disclaimer We are engaged in the business of advertising and promoting companies. All content on our website is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. Neither the information presented nor any statement or expression of opinion, or any other matter herein, directly or indirectly constitutes a solicitation of the purchase or sale of any securities. Neither the owner of Huge Alerts nor any of its members, officers, directors, contractors or employees are licensed broker-dealers, account representatives, market makers, investment bankers, investment advisers, analyst or underwriters. Investing in securities, including the securities of those companies profiled or discussed on this website is for individuals tolerant of high risks. Viewers should always consult with a licensed securities professional before purchasing or selling any securities of companies profiled or discussed on Huge Alerts. It is possible that a viewer's entire investment may be lost or impaired due to the speculative nature of the companies profiled. Remember, never invest in any security of a company profiled or discussed on this website unless you can afford to lose your entire investment. Also, investing in micro-cap securities is highly speculative and carries an extremely high degree of risk. Huge Alerts makes no recommendation that the securities of the companies profiled or discussed on this website should be purchased, sold or held by viewers that learn of the profiled companies through our website. Some of the content on this website contains "forward-looking statements." Such statements may be preceded by the words "intends," "may," "will," "plans," "expects," "anticipates," "projects," "predicts," "estimates," "aims," "believes," "hopes," "potential," or similar words. Forward-looking statements are not guarantees of future performance, are based on certain assumptions, and are subject to various known and unknown risks and uncertainties, many of which may be beyond a company's control, and cannot be predicted or quantified, and, consequently, actual results may differ materially from those expressed or implied by such forward-looking statements. It is hereby noted that forward-looking statements contained herein may include everything other than historical information, involve risk and uncertainties that may affect a company's actual results of operation. A company's actual performance could greatly differ from those described in any forward-looking statements or announcements mentioned on this website or the websites contained within. Factors that should be considered that could cause actual results to differ include: the size and growth of the market for the company's products; the company's ability to fund its capital requirements in the near term and in the long term; pricing pressures; unforeseen and/or unexpected circumstances in happenings; etc. and the risk factors and other factors set forth in the company's filings with the Securities and Exchange Commission. However, a company's past performance does not guarantee future results. Generally, the information regarding a company profiled or discussed on this website is provided from public sources hugealerts.com makes no representations, warranties or guarantees as to the accuracy or completeness of the information provided or discussed. Viewers should not rely solely on the information obtained through our website or in communications originating from our website. Viewers should use the information provided by us regarding the profiled companies as a starting point for additional independent research on the companies profiled or discussed in order to allow the viewer to form his or her own opinion regarding investing in the securities of such companies. Factual statements, or the similar, made by the profiled companies are made as of the date stated and are subject to change without notice and Huge Alerts has no obligation to update any of the information provided. Huge Alerts, its owners, officers, directors, contractors and employees are not responsible for errors and omissions. From time to time certain content on this website is written and published by our employees or third parties. In addition to information about our profiled companies, from time to time, our website will contain the symbols of companies and/or news feeds about companies that are not being profiled by us but are merely illustrative of certain activity in the micro cap or penny stock market that we are highlighting. Viewers are advised that all analysis reports and news feeds are issued solely for informational purposes. Any opinions expressed are subject to change without notice. It is also possible that one or more of the companies discussed or profiled on this website may not have approved certain or any statements within the website. Huge Alerts encourages viewers to supplement the information obtained from this website with independent research and other professional advice. The content on this website is based on sources which we believe to be reliable but is not guaranteed by us as being accurate and does not purport to be a complete statement or summary of the available data. Third Party Web Sites and Other Information This website may provide hyperlinks to third party websites or access to third party content.Huge Alerts, its owners, officers, directors, contractors and employees are not responsible for errors and omissions nor does Huge Alerts control, endorse, or guarantee any content found in such sites. Huge Alerts does not control, endorse, or guarantee content found in such sites. By accessing, viewing, or using the website or communications originating from the website, you agree that Huge Alerts, its owners, officers, directors, contractors and employees, are not responsible for any content, associated links, resources, or services associated with a third party website. You further agree that Huge Alerts, its owners, officers, directors, contractors and employees shall not be liable for any loss or damage of any sort associated with your use of third party content. Links and access to these sites are provided for your convenience only. Huge Alerts uses third parties to disseminate information to subscribers. Although we take precautions to prevent others from obtaining our subscriber list, there is a risk that our subscriber list, through no wrong doing on our part, could end up in the hands of an unauthorized party and that subscribers will receive communications from unauthorized third parties. We encourage viewers to invest carefully and read the investor issuer information available at the web sites of the United States Securities and Exchange Commission (SEC). The SEC has launched an investor-focused website to help you invest wisely and avoid fraud at www.investor.gov and filings made by public companies can be viewed at www.sec.gov and/or the Financial Industry Regulatory Authority (FINRA) at: www.finra.org. In addition, FINRA has published information at its website on how to invest carefully at www.finra.org/Investors/index.htm. Income Disclaimer Testimonials and examples used here are exceptional results which may not apply to the average purchaser. They are not intended to represent or guarantee that anyone will achieve the same or similar results through our service. The use of our information should be based on your own due diligence, and you agree that our company is not liable for any success or failure of your business that is directly or indirectly related to the use of our information. As with any business, your results may vary, and will be based on your individual capacity, business experience and expertise. There are no guarantees concerning the level of success you may experience. Income statements made by our customers are only estimates of what they have earned; there is no guarantee that you will make these levels of income. When using our information you accept the risk that these earnings and income statements differ by individual. There is no assurance that examples of past earnings can be duplicated in the future. There are unknown risks in business and on the internet that we cannot anticipate which can reduce results. We therefore cannot guarantee your future results or success, and are not responsible for your actions. Huge Alerts has been retained by Biostem Technologies (OTC:BSEM) to perform promotional and advertising services for a limited time with respect to the company we are profiling or discussing on this website and in exchange for such services has received cash compensation from Biostem Technologies (OTC:BSEM). Questions regarding this website may be sent to editor@hugealerts.com Huge Alerts has an ongoing agreement with Biostem Technologies (OTC:BSEM) for the total sum of $350,000.00 This agreement is for the marketing of Biostem Technologies (OTC:BSEM) which services include the issuance of this release and other opinions that we release concerning of Biostem Technologies (OTC:BSEM). The Owner(s) of huge alerts own 29,500 free trading  shares of  Biostem Technologies (OTCS:BSEM) and 50,000 restricted shares. for the purpose of this disclaimer assume that the owners of huge alerts will sell every share at any time. Huge Alerts has not investigated the background of Biostem Technologies (OTC:BSEM) the hiring party, or Biostem Technologies (OTC:BSEM) Anyone viewing this newsletter should assume Biostem Technologies (OTC:BSEM) or affiliates of Biostem Technologies (OTC:BSEM) own shares of the Biostem Technologies (OTC:BSEM)) which they plan to liquidate, and further understand that the liquidation of those shares may or may not negatively impact the share price. Huge Alerts has received this amount as a production budget for advertising efforts and will retain amounts over and above the cost of production, copywriting services, mailing and other distribution expenses as a fee for our services. As such, our opinion is neither unbiased nor independent, and you should consider that when evaluating our statements regarding Biostem Technologies (OTC:BSEM)

 

1389 Center Dr
Park City UT 84098
USA

Unsubscribe   |   Change Subscriber Options